BIOMAT Database Logo BIOMAT Database Logo

Omeprazole is superior to ranitidine plus metoclopramide in the short-term treatment of erosive oesophagitis. 1993

M Robinson, and D L Decktor, and P N Maton, and S Sabesin, and W Roufail, and D Kogut, and W Roberts, and A McCullough, and P Pardoll, and L Saco
Oklahoma Foundation for Digestive Research, Oklahoma City 73104.

Histamine H2-receptor antagonists are moderately effective in symptomatic treatment and healing of erosive oesophagitis, but they are not as effective as the proton pump inhibitor omeprazole. In some studies prokinetic agents seem to increase the effectiveness of H2-antagonists, but no study comparing the efficacy of omeprazole to H2-antagonists plus prokinetic agents has been performed. The purpose of this study was to compare the efficacy and tolerability of 20 mg omeprazole daily with 150 mg ranitidine b.d.s. plus the prokinetic agent 10 mg metoclopramide q.d.s. in patients with erosive oesophagitis. After both 4 and 8 weeks of treatment, omeprazole healed the mucosa in significantly more patients than did ranitidine plus metoclopramide. Omeprazole also provided significantly greater relief from daytime heartburn, nighttime heartburn, and acid regurgitation, and was associated with decreased concomitant antacid use. Although the overall incidence of adverse events was similar in the two treatment groups, a significantly higher number of treatment-related adverse events and more treatment-related withdrawals from the study occurred in the ranitidine plus metoclopramide treatment group. Omeprazole is more effective and better tolerated than the combination of standard dose ranitidine plus metoclopramide for patients with erosive oesophagitis.

UI MeSH Term Description Entries
D008297 Male Males
D008787 Metoclopramide A dopamine D2 antagonist that is used as an antiemetic. 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide,Cerucal,Maxolon,Metaclopramide,Metoclopramide Dihydrochloride,Metoclopramide Hydrochloride,Metoclopramide Monohydrochloride,Metoclopramide Monohydrochloride, Monohydrate,Primperan,Reglan,Rimetin,Dihydrochloride, Metoclopramide,Hydrochloride, Metoclopramide,Monohydrochloride, Metoclopramide
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009853 Omeprazole A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. H 168-68,Omeprazole Magnesium,Omeprazole Sodium,Prilosec,H 168 68,H 16868,Magnesium, Omeprazole,Sodium, Omeprazole
D011899 Ranitidine A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. AH-19065,Biotidin,N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine,Ranisen,Ranitidin,Ranitidine Hydrochloride,Sostril,Zantac,Zantic,AH 19065,AH19065,Hydrochloride, Ranitidine
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004942 Esophagitis, Peptic INFLAMMATION of the ESOPHAGUS that is caused by the reflux of GASTRIC JUICE with contents of the STOMACH and DUODENUM. Esophagitis, Reflux,Esophagitides, Peptic,Esophagitides, Reflux,Peptic Esophagitides,Peptic Esophagitis,Reflux Esophagitides,Reflux Esophagitis
D005260 Female Females
D005764 Gastroesophageal Reflux Retrograde flow of gastric juice (GASTRIC ACID) and/or duodenal contents (BILE ACIDS; PANCREATIC JUICE) into the distal ESOPHAGUS, commonly due to incompetence of the LOWER ESOPHAGEAL SPHINCTER. Esophageal Reflux,Gastro-Esophageal Reflux Disease,GERD,Gastric Acid Reflux,Gastric Acid Reflux Disease,Gastro-Esophageal Reflux,Gastro-oesophageal Reflux,Gastroesophageal Reflux Disease,Reflux, Gastroesophageal,Acid Reflux, Gastric,Gastro Esophageal Reflux,Gastro Esophageal Reflux Disease,Gastro oesophageal Reflux,Gastro-Esophageal Reflux Diseases,Reflux Disease, Gastro-Esophageal,Reflux, Gastric Acid,Reflux, Gastro-Esophageal,Reflux, Gastro-oesophageal

Related Publications

M Robinson, and D L Decktor, and P N Maton, and S Sabesin, and W Roufail, and D Kogut, and W Roberts, and A McCullough, and P Pardoll, and L Saco
Omeprazole or ranitidine plus metoclopramide for patients with severe erosive oesophagitis. A cost-effectiveness analysis.
October 1995, PharmacoEconomics,
M Robinson, and D L Decktor, and P N Maton, and S Sabesin, and W Roufail, and D Kogut, and W Roberts, and A McCullough, and P Pardoll, and L Saco
Omeprazole versus ranitidine in erosive oesophagitis.
September 1987, Lancet (London, England),
M Robinson, and D L Decktor, and P N Maton, and S Sabesin, and W Roufail, and D Kogut, and W Roberts, and A McCullough, and P Pardoll, and L Saco
Omeprazole in the treatment of erosive oesophagitis refractory to high dose cimetidine and ranitidine.
July 1990, Gut,
M Robinson, and D L Decktor, and P N Maton, and S Sabesin, and W Roufail, and D Kogut, and W Roberts, and A McCullough, and P Pardoll, and L Saco
Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis.
May 1988, Digestive diseases and sciences,
M Robinson, and D L Decktor, and P N Maton, and S Sabesin, and W Roufail, and D Kogut, and W Roberts, and A McCullough, and P Pardoll, and L Saco
Omeprazole in short term treatment of reflux oesophagitis.
December 1992, JPMA. The Journal of the Pakistan Medical Association,
M Robinson, and D L Decktor, and P N Maton, and S Sabesin, and W Roufail, and D Kogut, and W Roberts, and A McCullough, and P Pardoll, and L Saco
Omeprazole in the short-term treatment of reflux oesophagitis.
January 1989, Digestion,
M Robinson, and D L Decktor, and P N Maton, and S Sabesin, and W Roufail, and D Kogut, and W Roberts, and A McCullough, and P Pardoll, and L Saco
Comparison of omeprazole with ranitidine in the treatment of reflux oesophagitis.
January 1989, Scandinavian journal of gastroenterology. Supplement,
M Robinson, and D L Decktor, and P N Maton, and S Sabesin, and W Roufail, and D Kogut, and W Roberts, and A McCullough, and P Pardoll, and L Saco
Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis.
December 1993, Archives of disease in childhood,
M Robinson, and D L Decktor, and P N Maton, and S Sabesin, and W Roufail, and D Kogut, and W Roberts, and A McCullough, and P Pardoll, and L Saco
Comparison of ranitidine, domperidone maleate and ranitidine + domperidone maleate in the short-term treatment of reflux oesophagitis.
January 1985, Drugs under experimental and clinical research,
M Robinson, and D L Decktor, and P N Maton, and S Sabesin, and W Roufail, and D Kogut, and W Roberts, and A McCullough, and P Pardoll, and L Saco
Long-term maintenance treatment with omeprazole in children with healed erosive oesophagitis: a prospective study.
February 2012, Alimentary pharmacology & therapeutics,
Copied contents to your clipboard!